Logo
M

MacroGenics, Inc.

393 employees

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Autoimmune Disorders
Therapeutics
Infectious Diseases
Fc Optimization
Monoclonal Antibodies
Bi-Specific Antibodies
Medical
Health Care
Oncology
Manufacturing

Date founded

2000

Funding rounds raised

Total raised

$45M

from 33 investors over 33 rounds

M

MacroGenics, Inc. raised $9.8M on July 15, 2010

Investors: National Institutes of Health

M

MacroGenics, Inc. raised $25M on October 23, 2008

Investors: RiverVest Venture Partners, Nextech Venture, Bank of Tokyo-Mitsubishi UFJ, Ventures West, TPG Global, OrbiMed Advisors and InterWest Partners

M

MacroGenics, Inc. raised $13M on July 29, 2008

Investors: Clarus Ventures, LLC, Alta Partners, InterWest Partners and TPG Global

M

MacroGenics, Inc. raised $45M on May 17, 2006

Investors: RiverVest Venture Partners, Caisse de dépôt et placement du Québec (CDPQ), Biogen Idec, TPG Global, OrbiMed Advisors, MPM Capital, Ventures West and Alta Partners

M

MacroGenics, Inc. raised $31M on October 15, 2004

Investors: Vivo Capital, TPG Global, MPM Capital, Alta Partners, OrbiMed Advisors and InterWest Partners

M

MacroGenics, Inc. raised $13M on June 7, 2002

Investors: MPM Capital, OrbiMed Advisors, STARTech Early Ventures and InterWest Partners

M

MacroGenics, Inc. raised $14M on September 25, 2001

Investors: InterWest Partners, MPM Capital and OrbiMed Advisors

FAQ